Christopher Martin

Christopher John Martin is the founder of Paras Ltd., founded in 1994.
Dr. Martin is the founder of Xenva Ltd., founded in 1998.
Dr. Martin is the founder of Sciona, Inc., founded in 2000.
Dr. Martin was the founder of ADC Products (UK) Ltd., founded in 2000, and held the title of Director from 2000 to 2016.
Dr. Martin was the founder of ADC Therapeutics SA, founded in 2011, and held the title of Non-Executive Director from 2022 to 2023.
Dr. Martin was the founder of Spirogen SARL, founded in 2011, and held the title of Chief Executive Officer from 2011 to 2013.
Dr. Martin is also the founder of Xenova Ltd...
Current jobs include Non-Executive Chairman at Tokamak Energy Ltd., Chairman at Tagworks Pharmaceuticals BV, Independent Chairman at Myricx Pharma Ltd. since 2023, Chairman at Newron Pharmaceuticals SpA starting 2025, Director at Cascade Fund Management Ltd., Director at Xenva Ltd. since 1998, Director at Osivax SAS since 2023, and Director at Solcom Ltd. Former jobs include Independent Non-Executive Director at Allianz Technology Trust Plc from 2010 to 2015, Director at Solcom Ltd., Member at AstraZeneca PLC, and Member-Management Board at MedImmune Pharma BV.
Education includes a doctorate from the University of Oxford, an MBA from the International Institute for Management Development, and an undergraduate degree from the University of Aston.